Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
9
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Mister Spex
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
SpexFocus Program Will Streamline Operations And Reduce Complexity
Key Takeaways SpexFocus program aims to improve net margins by reducing overhead and streamlining operations, enhancing operational efficiency. Shift towards profitable offline business with new services and pricing strategies to boost revenue and gross margins.
View narrative
€4.10
FV
54.3% undervalued
intrinsic discount
-2.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Fluent
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Commerce Media Solutions Will Open New Market Opportunities
Key Takeaways Fluent's focus on high-margin Commerce Media Solutions and major partnerships is expected to significantly boost revenue and market share. Strategic investment in AI technology and first-party data enhances efficiency, profitability, and positions Fluent in the growing commerce media industry.
View narrative
US$3.00
FV
37.0% undervalued
intrinsic discount
7.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Surf Air Mobility
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Urban Air Mobility And Electrification Will Drive Expansion
Key Takeaways Strong growth is driven by demand for regional air mobility, digital innovation, and a shift to electric aircraft for future margin expansion. Operational efficiency gains and a strengthened balance sheet support profitability and position the company well for scalable growth.
View narrative
US$7.50
FV
41.3% undervalued
intrinsic discount
35.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
7 days ago
author updated this narrative
Orexo
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Zubsolv Litigation Settlement And OX640 Progress Will Secure Stability
Key Takeaways Legal settlements and strategic changes stabilize revenue streams, enhancing future planning and financial clarity for Orexo. Advancements in product development and strategic partnerships signal potential growth in revenue and net margins.
View narrative
SEK 21.50
FV
1.4% undervalued
intrinsic discount
1.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Jushi Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Pennsylvania And Virginia Reforms Will Unlock New Market Opportunities
Key Takeaways Regulatory changes in key states and at the federal level could unlock new markets, enhance margins, and increase liquidity for Jushi. Strategic retail expansion and product innovation are expected to drive higher revenue, lower costs, and capture greater market share.
View narrative
US$1.00
FV
33.6% undervalued
intrinsic discount
8.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
U.S. Energy
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Montana Industrial Gas Project Will Unlock Future Opportunities
Key Takeaways Expansion into specialty gases and integrated carbon management diversifies revenue streams, reduces reliance on oil cycles, and enhances long-term earnings visibility. Strong financial position and operational efficiencies enable opportunistic investment, improved profitability, and resilience against commodity price volatility.
View narrative
US$2.83
FV
58.4% undervalued
intrinsic discount
13.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Rockwell Medical
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Dialysis Demand Will Grow Despite Margin And Market Challenges
Key Takeaways Increased demand for dialysis solutions and successful long-term contracts drive stable growth and revenue visibility, especially as the company enters new and underserved markets. Operational improvements and a strong reputation enhance margins and market share, with expanded access and customer acquisitions supporting further revenue gains.
View narrative
US$4.00
FV
71.1% undervalued
intrinsic discount
-6.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
7 days ago
author updated this narrative
Clearside Biomedical
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
FDA Alignment And Phase 3 Trials Will Advance AMD Therapy
Key Takeaways FDA alignment on CLS-AX for wet AMD and Phase 2b outcomes may boost revenues and market leadership upon approval. Global partnerships and SCS technology expansions could enhance international market presence and revenue streams.
View narrative
US$4.00
FV
89.9% undervalued
intrinsic discount
38.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
7 days ago
author updated this narrative
Laird Superfood
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Retail Expansion And Clean Label Trends Will Support Future Value
Key Takeaways Expanding retail distribution and ongoing product innovation position the company to diversify revenues, tap into new markets, and meet rising demand for functional, clean-label foods. Operational improvements, cost discipline, and a strong balance sheet reduce financial risk, supporting sustained gross margins and enabling long-term growth investments.
View narrative
US$12.67
FV
55.8% undervalued
intrinsic discount
20.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
7 days ago
author updated this narrative
Value any company in seconds
Popular companies